SPOTLIGHT: GSK prepares pipeline update

Analysts are keenly awaiting tomorrow's presentation by GlaxoSmithKline on its brightest pipeline hopes. GSK is betting that its experimental vaccines -- like Cervarix -- can rev up its bottom line. Story

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.